Cigna (CI) insider: 290 shares withheld at $300.66 for taxes

David J. Brailer, EVP & Chief Health Officer of The Cigna Group (CI), reported a transaction on 08/29/2025 showing 290 shares of Cigna common stock were disposed of at a price of $300.66 per share.

Rhea-AI Filing Summary

David J. Brailer, EVP & Chief Health Officer of The Cigna Group (CI), reported a transaction on 08/29/2025 showing 290 shares of Cigna common stock were disposed of at a price of $300.66 per share. The filing states these shares were withheld to satisfy tax obligations upon the vesting of restricted shares, not a market sale.

After the withholding, Mr. Brailer beneficially owns 17,525 shares of Cigna common stock. The Form 4 was executed by an attorney-in-fact and filed on 09/02/2025.

Positive

• Clear disclosure that the 290-share disposition was for tax withholding on vested restricted stock
• Compliance with Section 16 reporting, including execution by attorney-in-fact and timely filing

Negative

• None.

Insights

Securities Analyst

TL;DR Routine tax-withholding of vested restricted shares; immaterial to Cigna’s capital structure.

The reported 290-share disposition at $300.66 per share reflects tax withholding on vested restricted stock rather than an active open-market sale, which typically has minimal signaling value to investors. The remaining beneficial ownership of 17,525 shares provides context on the insider's stake size. No new derivative positions or additional dispositions are reported, and the transaction appears consistent with standard executive compensation mechanics.

Corporate Governance Expert

TL;DR Disclosure follows Section 16 requirements and clarifies the nature of the share transfer.

The Form 4 documents proper disclosure for an insider compensation-related withholding event. Filing by an attorney-in-fact is noted and acceptable when executed under power of attorney. The transaction description explicitly states tax-withholding as the reason, which helps distinguish it from trading for liquidity or other motives that might raise governance concerns.

Insider Trade Summary

Exercise Price or Tax Liability: 290 shares

Exercise Price or Tax Liability 1 txn

Insider BRAILER DAVID J

Role EVP & Chief Health Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock, $.01 Par Value	290	$300.66	$87K

Holdings After Transaction: Common Stock, $.01 Par Value — 17,525 shares (Direct)

Footnotes (1)

1. F1. Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did David J. Brailer report on Form 4 for CI?

He reported a disposition of 290 shares on 08/29/2025 at $300.66 per share, withheld to satisfy tax obligations on vested restricted shares.

How many Cigna (CI) shares does the reporting person own after the transaction?

The filing shows beneficial ownership of 17,525 shares following the reported transaction.

Was the 290-share transaction an open-market sale?

No. The Form 4 states the shares were withheld to satisfy tax obligations upon vesting of restricted shares.

Who signed and filed the Form 4 for David J. Brailer?

The form was executed by an attorney-in-fact, Tyler Gratton, and filed on 09/02/2025.

What is the price per share reported on the transaction?

The transaction price reported is $300.66 per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 09/03/2025 - 05:20 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BRAILER DAVID J

(Last) (First) (Middle)

900 COTTAGE GROVE ROAD

(Street)

BLOOMFIELD CT 06002

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Cigna Group [ CI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & Chief Health Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/29/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $.01 Par Value	08/29/2025		F		290(1)	D	$300.66	17,525	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.

	Tyler Gratton, attorney-in-fact	09/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.